Jericho Assisted Living
Wednesday, May 18, 2016
FDA: Canagliflozin Linked to Amputations in Post-Marketing Trial
(MedPage Today) -- Monitoring committee suggests that CANVAS trial continue
via
FDA: Canagliflozin Linked to Amputations in Post-Marketing Trial
by
No comments:
Post a Comment
Newer Post
Older Post
Home
Subscribe to:
Post Comments (Atom)
No comments:
Post a Comment